Fusidane antibiotics produced by dermatophytes

Area of Science:

• Medical Mycology
• Antimicrobial Resistance
• Dermatophytosis

Background:

• Dermatophytes like Microsporum canis, Microsporum gypseum, and Epidermophyton floccosum are common causes of fungal skin infections.
• Understanding microbial interactions and antibiotic production within the host environment is crucial for treating dermatophytosis.
• Cross-resistance to antibiotics can influence the efficacy of treatments and the dynamics of co-infections.

Purpose of the Study:

• To investigate the antibacterial activities produced by dermatophyte isolates.
• To identify the specific compounds responsible for observed antibacterial effects.
• To explore the potential role of these antibiotics in the pathogenesis of dermatophytosis.

Main Methods:

• Isolation and culture of Microsporum canis, Microsporum gypseum, and Epidermophyton floccosum.
• Assay of antibacterial activity against relevant bacterial species, particularly under conditions of cross-resistance to fusidic acid.
• Chemical characterization and identification of antibacterial compounds produced by E. floccosum.

Main Results:

• Dermatophyte isolates demonstrated significant antibacterial activities, especially when cross-resistant to fusidic acid.
• The antibacterial activity of Epidermophyton floccosum was attributed to the production of fusidic acid, diketofusidic acid, and 3-ketofusidic acid.
• These identified compounds suggest a potential role in the complex microbial ecology of dermatophytosis.

Conclusions:

• Dermatophytes can produce bioactive compounds with antibacterial properties, including fusidic acid derivatives.
• The production of these antibiotics by dermatophytes may influence bacterial populations and interactions during skin infections.
• Further research is warranted to elucidate the precise contribution of these fungal-derived antibiotics to the clinical presentation and treatment of dermatophytosis.